Tissue peptides
BPC-157
- 10 mg
Custom strengths on request
Not FDA-approved. Not on FDA's 503A category lists (May 14, 2026). Source, May 14, 2026
At a glance
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Start
10 mg (total), injected around the inflamed bladder area during cystoscopy
Human study
- Frequency
- Single procedure
- Route
- Around bladder inflammation during cystoscopy (reported as intravesical)
- Course
- Single administration; follow-up duration not stated
Human data are single 10 mg bladder-injection or 10 to 20 mg IV doses; no study tested repeated subcutaneous dosing.
Get a quote
Custom strengths on request. Prices are quoted per clinic.